Literature DB >> 7615907

The effect of GHRH on TSH release in rats in vivo and in vitro.

B J Looij1, A C Nieuwenhuijzen Kruseman, F Roelfsema, D van der Heide, R P Hoogma, J P Schröder-van der Elst.   

Abstract

In man, GHRH has been shown to potentiate the TSH-releasing activity of TRH. To study the way by which GHRH affects TRH-stimulated TSH release, we examined the effect of GHRH (1-29)NH2 on basal and stimulated TSH secretion in intact male rats and superfused dispersed rat pituitary cells. In the intact rats, GHRH(1-29)NH2 potentiated TRH-stimulated TSH release in the evening, but potentiation was not observed in the morning and in dispersed pituitary cells. Basal TSH levels were not changed by GHRH(1-29)NH2. It is concluded that GHRH(1-29)NH2 potentiates the TSH-releasing activity of TRH in the evening in rats possibly through suprahypophyseal disinhibition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615907     DOI: 10.1007/BF03347804

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.

Authors:  M Giusti; A Lomeo; G Mazzocchi; R Torre; M Monachesi; P Sessarego; R Attanasio; G Giordano
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

2.  [Global pituitary stimulation test with releasing hormones].

Authors:  R Holl; H L Fehm; W D Hetzel; E Heinze; K H Voigt
Journal:  Dtsch Med Wochenschr       Date:  1985-06-14       Impact factor: 0.628

Review 3.  Neuroendocrine control of thyrotropin secretion.

Authors:  J E Morley
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

4.  Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors.

Authors:  W B Wehrenberg; A Baird; S Y Ying; C Rivier; N Ling; R Guillemin
Journal:  Endocrinology       Date:  1984-06       Impact factor: 4.736

5.  Diurnal variations of plasma thyrotropin, thyroxine, and triiodothyronine in female rats are phase shifted after inversion of the photoperiod.

Authors:  J E Ottenweller; G A Hedge
Journal:  Endocrinology       Date:  1982-08       Impact factor: 4.736

6.  Contribution fron local conversion of thyroxine to 3,5,3'-triiodothyronine to intracellular 3,5,3'-triiodothyronine in several organs in hypothyroid rats at isotope equilibrium.

Authors:  J van Doorn; F Roelfsema; D van der Heide
Journal:  Acta Endocrinol (Copenh)       Date:  1982-11

7.  Pituitary stimulation by combined administration of four hypothalamic releasing hormones in normal men and patients.

Authors:  R Cohen; D Bouquier; S Biot-Laporte; E Vermeulen; B Claustrat; M H Cherpin; P Cabrera; P Guidetti; S Ferry; C A Bizollon
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

8.  Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.

Authors:  M L Vance; J L Borges; D L Kaiser; W S Evans; R Furlanetto; J L Thominet; L A Frohman; A D Rogol; R M MacLeod; S Bloom
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

9.  Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man.

Authors:  M O Thorner; J Rivier; J Spiess; J L Borges; M L Vance; S R Bloom; A D Rogol; M J Cronin; D L Kaiser; W S Evans; J D Webster; R M MacLeod; W Vale
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

10.  Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women.

Authors:  M C Gelato; O H Pescovitz; F Cassorla; D L Loriaux; G R Merriam
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.